• placebo
  • Personal testimonials describing low-dose naltrexone as a cure for multiple sclerosis are not supported by high quality evidence in large randomised , double-blind , placebo-controlled clinical trials. (wikipedia.org)
  • patients
  • Bowling noted that safety of low-dose naltrexone treatment for multiple sclerosis has not been assessed, and that patients who chose to undergo the treatment should be fully informed of the limited research backing its use. (wikipedia.org)
  • clinical
  • However, currently no peer-reviewed studies that would justify clinical use of low-dose naltrexone in treating Multiple Sclerosis (MS) have been published. (wikipedia.org)